Dongyue Group Limited (0189.HK)
HKD 7.6
(3.68%)
HKD 7.6
(3.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 14.49 Billion CNY | -27.63% |
| 2022 | 20.02 Billion CNY | 26.41% |
| 2021 | 15.84 Billion CNY | 57.74% |
| 2020 | 10.04 Billion CNY | -22.49% |
| 2019 | 12.95 Billion CNY | -8.86% |
| 2018 | 14.21 Billion CNY | 40.27% |
| 2017 | 10.13 Billion CNY | 27.19% |
| 2016 | 7.96 Billion CNY | 13.33% |
| 2015 | 7.03 Billion CNY | -7.46% |
| 2014 | 7.59 Billion CNY | 12.04% |
| 2013 | 6.78 Billion CNY | -3.8% |
| 2012 | 7.05 Billion CNY | -30.64% |
| 2011 | 10.16 Billion CNY | 70.43% |
| 2010 | 5.96 Billion CNY | 68.27% |
| 2009 | 3.54 Billion CNY | -10.54% |
| 2008 | 3.96 Billion CNY | 47.58% |
| 2007 | 2.68 Billion CNY | 33.84% |
| 2006 | 2 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.26 Billion CNY | 0.0% |
| 2023 Q4 | 7.29 Billion CNY | 0.0% |
| 2023 Q2 | 7.19 Billion CNY | 0.0% |
| 2023 FY | 14.49 Billion CNY | -27.63% |
| 2022 Q4 | 9.91 Billion CNY | 0.0% |
| 2022 Q2 | 10.11 Billion CNY | 0.0% |
| 2022 FY | 20.02 Billion CNY | 26.41% |
| 2021 Q4 | 9.37 Billion CNY | 0.0% |
| 2021 Q2 | 6.47 Billion CNY | 0.0% |
| 2021 FY | 15.84 Billion CNY | 57.74% |
| 2020 FY | 10.04 Billion CNY | -22.49% |
| 2020 Q4 | 5.4 Billion CNY | 0.0% |
| 2020 Q2 | 4.63 Billion CNY | 0.0% |
| 2019 FY | 12.95 Billion CNY | -8.86% |
| 2019 Q2 | 6.04 Billion CNY | 0.0% |
| 2019 Q4 | 6.91 Billion CNY | 0.0% |
| 2018 Q4 | 6.84 Billion CNY | 0.0% |
| 2018 FY | 14.21 Billion CNY | 40.27% |
| 2018 Q2 | 7.37 Billion CNY | 0.0% |
| 2017 Q2 | 4.78 Billion CNY | 0.0% |
| 2017 Q4 | 5.34 Billion CNY | 0.0% |
| 2017 FY | 10.13 Billion CNY | 27.19% |
| 2016 FY | 7.96 Billion CNY | 13.33% |
| 2016 Q2 | 3.82 Billion CNY | 0.0% |
| 2016 Q4 | 4.14 Billion CNY | 0.0% |
| 2015 Q2 | 3.67 Billion CNY | 0.0% |
| 2015 FY | 7.03 Billion CNY | -7.46% |
| 2015 Q4 | 3.35 Billion CNY | 0.0% |
| 2014 Q4 | 4.08 Billion CNY | 0.0% |
| 2014 Q2 | 3.51 Billion CNY | 0.0% |
| 2014 FY | 7.59 Billion CNY | 12.04% |
| 2013 FY | 6.78 Billion CNY | -3.8% |
| 2013 Q2 | 3.19 Billion CNY | 0.0% |
| 2013 Q4 | 3.58 Billion CNY | 0.0% |
| 2012 Q2 | 1.76 Billion CNY | 0.0% |
| 2012 Q3 | 1.76 Billion CNY | 0.0% |
| 2012 Q4 | 1.69 Billion CNY | -3.8% |
| 2012 Q1 | 1.76 Billion CNY | 0.0% |
| 2012 FY | 7.05 Billion CNY | -30.64% |
| 2011 FY | 10.16 Billion CNY | 70.43% |
| 2011 Q1 | 2.54 Billion CNY | 0.0% |
| 2011 Q2 | 2.54 Billion CNY | 0.0% |
| 2011 Q3 | 2.54 Billion CNY | 0.0% |
| 2011 Q4 | 1.76 Billion CNY | -30.64% |
| 2010 Q1 | 1.49 Billion CNY | 0.0% |
| 2010 FY | 5.96 Billion CNY | 68.27% |
| 2010 Q4 | 2.54 Billion CNY | 70.43% |
| 2010 Q3 | 1.49 Billion CNY | 0.0% |
| 2010 Q2 | 1.49 Billion CNY | 0.0% |
| 2009 FY | 3.54 Billion CNY | -10.54% |
| 2009 Q4 | 1.49 Billion CNY | 68.27% |
| 2009 Q3 | 886.11 Million CNY | 0.0% |
| 2009 Q2 | 886.11 Million CNY | 0.0% |
| 2009 Q1 | 886.11 Million CNY | 0.0% |
| 2008 Q4 | 886.11 Million CNY | -10.54% |
| 2008 Q2 | 990.53 Million CNY | 0.0% |
| 2008 Q1 | 990.53 Million CNY | 0.0% |
| 2008 Q3 | 990.53 Million CNY | 0.0% |
| 2008 FY | 3.96 Billion CNY | 47.58% |
| 2007 Q1 | 671.18 Million CNY | 0.0% |
| 2007 Q4 | 990.53 Million CNY | 47.58% |
| 2007 FY | 2.68 Billion CNY | 33.84% |
| 2007 Q3 | 671.18 Million CNY | 0.0% |
| 2007 Q2 | 671.18 Million CNY | 0.0% |
| 2006 Q2 | 501.48 Million CNY | 0.0% |
| 2006 Q1 | 501.48 Million CNY | 0.0% |
| 2006 FY | 2 Billion CNY | 0.0% |
| 2006 Q4 | 671.18 Million CNY | 33.84% |
| 2006 Q3 | 501.48 Million CNY | 0.0% |
| 2005 Q4 | 501.48 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 773.65 Million HKD | -1773.36% |
| Lee & Man Chemical Company Limited | 4.05 Billion HKD | -257.808% |